Double maintains 3 strategies that include ARQT - Arcutis Biotherapeutics, Inc.
Current Value
$13.781 Year Return
Current Value
$13.781 Year Return
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| CNC | 0.03% | $16.81B | -49.40% | 0.00% |
| MDLZ | -0.06% | $90.07B | +4.85% | 2.72% |
| TEF | -0.07% | $30.08B | +25.41% | 6.16% |
| NHTC | -0.27% | $52.73M | -34.10% | 17.43% |
| UUU | -0.29% | $7.17M | +101.30% | 0.00% |
| VSTA | 0.29% | $344.07M | +39.29% | 0.00% |
| ZCMD | 0.29% | $29.55M | -8.59% | 0.00% |
| WEC | -0.29% | $33.11B | +33.56% | 3.32% |
| CYD | 0.31% | $890.68M | +164.07% | 3.83% |
| PRPH | -0.36% | $16.77M | -88.88% | 0.00% |
| DUK | 0.40% | $90.99B | +17.25% | 3.56% |
| CAG | 0.52% | $10.09B | -24.85% | 6.62% |
| SYPR | -0.56% | $48.49M | +14.05% | 0.00% |
| PSQH | 0.77% | $98.82M | -36.55% | 0.00% |
| KR | 0.89% | $46.43B | +38.38% | 1.85% |
| GFI | -0.92% | $21.56B | +57.55% | 2.31% |
| COR | 0.92% | $56.44B | +30.86% | 0.74% |
| GALT | 1.06% | $137.34M | +0.93% | 0.00% |
| TMUS | -1.09% | $269.58B | +33.04% | 1.38% |
| FAT | 1.18% | $43.84M | -3.17% | 11.48% |
SeekingAlpha
Arcutis Biotherapeutics: A Closer Look At The Atopic Dermatitis Direction
Finnhub
WESTLAKE VILLAGE - Arcutis Biotherapeutics, Inc. , a commercial-stage biopharmaceutical company dedicated to developing meaningful innovations in immuno-dermatology, announced that ZORYVE cream 0.15%...
Yahoo
The American Academy of Dermatology (AAD) provided evidence-based recommendation for the use of ZORYVE® (roflumilast) cream 0.15% in adults with mild to moderate atopic dermatitis (AD)Recommendation reflects ZORYVE’s proven efficacy, safety, and tolerability as a next-generation, steroid-free, topical phosphodiesterase-4 (PDE4) inhibitorAmong newly evaluated branded topical therapies, ZORYVE is the only treatment with a strong recommendation for adults with mild to moderate atopic dermatitis in
Finnhub
Arcutis Biotherapeutics, Inc. announced that ZORYVE®? cream 0.15% has received a strong recommendation in the focused guideline update for the management of adult AD from AAD from AAD. The...
SeekingAlpha
AMG GW&K Small Cap Core Fund Q1 2025 Commentary
SeekingAlpha
Arcutis Biotherapeutics: Another Approval Under Their Belt
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| NRIX | 46.12% | $948.37M | -35.91% | 0.00% |
| BEAM | 43.63% | $2.00B | -15.33% | 0.00% |
| KRYS | 43.29% | $4.08B | -20.39% | 0.00% |
| IDYA | 43.16% | $1.92B | -34.15% | 0.00% |
| OCUL | 42.53% | $1.51B | +41.41% | 0.00% |
| ROIV | 41.70% | $7.46B | +4.68% | 0.00% |
| DNLI | 40.62% | $2.16B | -30.05% | 0.00% |
| BLFS | 40.24% | $1.08B | +13.58% | 0.00% |
| XENE | 40.04% | $2.56B | -7.61% | 0.00% |
| MFC | 39.80% | $53.86B | +17.22% | 3.79% |
| CYTK | 39.40% | $4.10B | -36.84% | 0.00% |
| GNRC | 38.97% | $8.90B | +9.12% | 0.00% |
| APGE | 38.88% | $2.64B | +18.19% | 0.00% |
| DAWN | 38.62% | $682.17M | -50.15% | 0.00% |
| ATXS | 38.27% | $323.37M | -36.33% | 0.00% |
| RICK | 38.03% | $354.83M | +0.52% | 0.69% |
| DOCN | 37.38% | $2.59B | -18.46% | 0.00% |
| XNCR | 37.29% | $590.72M | -55.40% | 0.00% |
| SYRE | 37.27% | $935.48M | -39.83% | 0.00% |
| VSH | 37.01% | $2.31B | -23.47% | 2.34% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| ED | -11.49% | $36.00B | +12.64% | 3.34% |
| CBOE | -11.13% | $24.23B | +35.36% | 1.09% |
| MO | -8.85% | $99.67B | +28.77% | 6.90% |
| K | -6.96% | $27.76B | +41.17% | 2.85% |
| BTCT | -6.82% | $25.56M | +61.14% | 0.00% |
| MNOV | -6.04% | $62.29M | -9.29% | 0.00% |
| CARV | -5.61% | $8.88M | +26.23% | 0.00% |
| SAVA | -5.38% | $97.10M | -81.34% | 0.00% |
| AWK | -5.29% | $27.36B | +9.65% | 2.21% |
| DFDV | -4.43% | $300.56M | +2,130.16% | 0.00% |
| RRGB | -4.38% | $122.20M | +4.87% | 0.00% |
| KMB | -4.31% | $43.92B | -3.75% | 3.75% |
| VZ | -4.17% | $183.79B | +6.01% | 6.18% |
| LITB | -3.72% | $21.24M | -78.57% | 0.00% |
| CL | -3.46% | $74.88B | -3.64% | 2.19% |
| PCRX | -3.45% | $1.07B | +7.16% | 0.00% |
| EXC | -3.36% | $43.33B | +23.58% | 3.62% |
| VSA | -3.05% | $8.67M | -19.04% | 0.00% |
| PPC | -2.71% | $10.84B | +33.46% | 0.00% |
| ASPS | -2.55% | $108.30M | -4.13% | 0.00% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| VIXY | -34.08% | $164.54M | 0.85% |
| BTAL | -30.42% | $296.22M | 1.43% |
| TAIL | -28.28% | $99.63M | 0.59% |
| USDU | -12.23% | $162.43M | 0.5% |
| TPMN | -11.45% | $30.70M | 0.65% |
| UUP | -11.34% | $201.63M | 0.77% |
| CLIP | -9.33% | $1.51B | 0.07% |
| IVOL | -8.81% | $347.03M | 1.02% |
| GBIL | -7.63% | $6.37B | 0.12% |
| BIL | -7.50% | $42.24B | 0.1356% |
| TBIL | -7.03% | $5.81B | 0.15% |
| FTSD | -6.11% | $231.81M | 0.25% |
| TBLL | -4.49% | $2.13B | 0.08% |
| ULST | -3.93% | $654.75M | 0.2% |
| KRBN | -3.88% | $160.17M | 0.85% |
| FXY | -3.63% | $816.38M | 0.4% |
| SGOV | -3.57% | $49.21B | 0.09% |
| TFLO | -3.33% | $6.82B | 0.15% |
| SHV | -2.00% | $20.64B | 0.15% |
| PSQA | -2.00% | $35.44M | 0.2% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| IBMN | -0.08% | $447.08M | 0.18% |
| XONE | -0.58% | $625.28M | 0.03% |
| STOT | 0.77% | $254.07M | 0.45% |
| CTA | -1.43% | $1.06B | 0.76% |
| BUXX | 1.47% | $315.18M | 0.25% |
| XBIL | 1.47% | $783.90M | 0.15% |
| SPTS | 1.66% | $5.80B | 0.03% |
| AGZD | -1.79% | $102.70M | 0.23% |
| WEAT | 1.92% | $117.15M | 0.28% |
| PSQA | -2.00% | $35.44M | 0.2% |
| SHV | -2.00% | $20.64B | 0.15% |
| KMLM | 2.06% | $188.90M | 0.9% |
| UNG | 2.44% | $360.54M | 1.06% |
| CORN | 2.45% | $44.67M | 0.2% |
| CANE | 3.24% | $10.37M | 0.29% |
| TFLO | -3.33% | $6.82B | 0.15% |
| JUCY | 3.54% | $269.70M | 0.6% |
| CCOR | 3.54% | $51.66M | 1.18% |
| SGOV | -3.57% | $49.21B | 0.09% |
| FXY | -3.63% | $816.38M | 0.4% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| XBI | 54.09% | $4.82B | 0.35% |
| PINK | 51.76% | $130.57M | 0.5% |
| GNOM | 51.13% | $44.57M | 0.5% |
| PBE | 49.23% | $223.19M | 0.58% |
| IBB | 49.06% | $5.26B | 0.45% |
| PTH | 48.49% | $100.85M | 0.6% |
| ARKG | 46.09% | $1.02B | 0.75% |
| IWO | 44.69% | $11.60B | 0.24% |
| KJAN | 43.66% | $287.30M | 0.79% |
| BBH | 43.59% | $330.62M | 0.35% |
| FBT | 43.42% | $1.01B | 0.54% |
| IWC | 42.92% | $818.14M | 0.6% |
| KOMP | 42.41% | $2.29B | 0.2% |
| VTWO | 42.13% | $12.52B | 0.07% |
| IWM | 42.13% | $63.72B | 0.19% |
| QQQJ | 42.03% | $621.52M | 0.15% |
| ISCG | 41.94% | $681.20M | 0.06% |
| VBK | 41.79% | $19.01B | 0.07% |
| ROBT | 41.51% | $498.76M | 0.65% |
| ARKX | 41.28% | $341.31M | 0.75% |
